Overview
Gerburg Wulf is an Oncologist in Boston, Massachusetts. Dr. Wulf is rated as a Distinguished provider by MediFind in the treatment of Triple-Negative Breast Cancer. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, Triple-Negative Breast Cancer, and Hormone Replacement Therapy (HRT). Dr. Wulf is currently accepting new patients.
Her clinical research consists of co-authoring 73 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles and participated in 1 clinical trial in the study of Triple-Negative Breast Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
330 Brookline Ave, Boston, MA 02215
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
9 Clinical Trials
Dana-Farber Cancer Institute, Inc.
Sara Tolaney is a Hematologist Oncology specialist and an Oncologist in Boston, Massachusetts. Dr. Tolaney is rated as an Elite provider by MediFind in the treatment of Triple-Negative Breast Cancer. Her top areas of expertise are Breast Cancer, HER-2 Positive Breast Cancer, Triple-Negative Breast Cancer, and Inflammatory Breast Cancer. Dr. Tolaney is currently accepting new patients.
Dana-Farber Cancer Institute, Inc.
Filipa Lynce is an Oncologist and a Hematologist in Boston, Massachusetts. Dr. Lynce is rated as a Distinguished provider by MediFind in the treatment of Triple-Negative Breast Cancer. Her top areas of expertise are Inflammatory Breast Cancer, Breast Cancer, Triple-Negative Breast Cancer, Angiosarcoma, and Salpingo-Oophorectomy. Dr. Lynce is currently accepting new patients.
Dana-Farber Cancer Institute, Inc.
Nancy Lin is a Hematologist Oncology specialist and a Hematologist in Boston, Massachusetts. Dr. Lin is rated as an Elite provider by MediFind in the treatment of Triple-Negative Breast Cancer. Her top areas of expertise are Breast Cancer, Brain Tumor, HER-2 Positive Breast Cancer, and Inflammatory Breast Cancer. Dr. Lin is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Breast CancerDr. Wulf isElite. Learn about Breast Cancer.
- Distinguished
- AngiosarcomaDr. Wulf isDistinguished. Learn about Angiosarcoma.
- Inflammatory Breast CancerDr. Wulf isDistinguished. Learn about Inflammatory Breast Cancer.
- Paget Disease of the BreastDr. Wulf isDistinguished. Learn about Paget Disease of the Breast.
- Triple-Negative Breast CancerDr. Wulf isDistinguished. Learn about Triple-Negative Breast Cancer.
- Advanced
- ALK-Positive Non-Small Cell Lung Cancer
- BRCA Positive Breast CancerDr. Wulf isAdvanced. Learn about BRCA Positive Breast Cancer.
- HER2 Negative Breast CancerDr. Wulf isAdvanced. Learn about HER2 Negative Breast Cancer.
- Pleuropulmonary BlastomaDr. Wulf isAdvanced. Learn about Pleuropulmonary Blastoma.
- Small Cell Lung Cancer (SCLC)Dr. Wulf isAdvanced. Learn about Small Cell Lung Cancer (SCLC).
- Squamous Cell Lung CarcinomaDr. Wulf isAdvanced. Learn about Squamous Cell Lung Carcinoma.
- Experienced
- Cervical CancerDr. Wulf isExperienced. Learn about Cervical Cancer.
- EGFR Positive Lung CancerDr. Wulf isExperienced. Learn about EGFR Positive Lung Cancer.
- Familial Colorectal CancerDr. Wulf isExperienced. Learn about Familial Colorectal Cancer.
- Hormone Replacement Therapy (HRT)Dr. Wulf isExperienced. Learn about Hormone Replacement Therapy (HRT).
- Large-Cell Lung CarcinomaDr. Wulf isExperienced. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Wulf isExperienced. Learn about Lung Adenocarcinoma.